Your Input: | |||||
| BCL2L14 | BCL2 like 14. (329 aa) | ||||
| BCL2L12 | BCL2 like 12. (255 aa) | ||||
| BCL2L10 | Uncharacterized protein. (184 aa) | ||||
| BAK1 | Uncharacterized protein. (266 aa) | ||||
| BCL2L1 | Bcl-2-like protein 1; Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage- dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis. Regulates presynaptic plasticity, including neurotransmitter release and recovery, number of axonal mitochondria as well as size and number of synaptic vesicle clusters. During synaptic stimulation, increases ATP availab [...] (233 aa) | ||||
| BCL2A1 | Bcl-2-related protein A1 isoform 1. (175 aa) | ||||
| BCL2L15 | Bcl-2-like protein 15. (163 aa) | ||||
| PABPN1 | BCL2L2-PABPN1 protein. (333 aa) | ||||
| BID | BH3-interacting domain death agonist p11; Induces caspases and apoptosis. Counters the protective effect of Bcl-2. The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). (205 aa) | ||||
| MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1. (351 aa) | ||||
| BCL2L13 | BCL2 like 13. (470 aa) | ||||